Article
Ailanthone inhibits non-small cell lung cancer cell growth through repressing DNA replication via downregulating RPA1
12 Oct 2017
Abstract excerpt
BACKGROUND: The identification of bioactive compounds from Chinese medicine plays a crucial role in the development of novel reagents against non-small lung cancer (NSCLC). METHODS: High throughput screening assay and analyses of cell growth, cell cycle, apoptosis, cDNA microarray, BrdU incorporation and gene expression were performed. RESULTS: Ailanthone (Aila) suppressed NSCLC cell growth and colony formation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
